SEC Form 4 · accession 0001683168-18-002014
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Schutz
Officer — Chief Executive Officer · Director
Period of report
Jul 20, 2018
Accepted (ET)
Jul 24, 2018 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1 | $2.41 | Jul 20, 2018 | A | 67,733 | A | Jul 20, 2018 | Jul 20, 2028 | Common Stock | 67,733 | 193,358 | D |
Explanation of responses
- F1The options were awarded and granted to Mr. Schutz as a bonus for fiscal year 2018.